The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Open accessAbstract
Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 has been previously identified as a key cytokine that directly induces tumuor growth in CRC via STAT3 activation in IECs.12,15,46,47.”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 577
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citation
Research works printed but not linked: 1
- Jerry, 1993, Cancer Res., 53, 3374
Cited by
Sorted by citations
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 904
Advances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 896
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Jung, G., Hernández-Illán, E., Moreira, L., Balaguer, F., & Goel, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0230-y · Cited by 813
Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Du, B., & Shim, J. S. (2016) · Molecules · doi:10.3390/molecules21070965 · Cited by 829
The inflammatory pathogenesis of colorectal cancer
Schmitt, M., & Greten, F. R. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00534-x · Cited by 840
Self-citationmiRNA Deregulation in Cancer Cells and the Tumor Microenvironment
Rupaimoole, R., Călin, G. A., Lopez‐Berestein, G., & Sood, A. K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0893 · Cited by 705
Interleukin-6 and its receptors: a highly regulated and dynamic system
Wolf, J., Rose-John, S., & Garbers, C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.05.024 · Cited by 618
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D. D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 573
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment
Chikara, S., Nagaprashantha, L. D., Singhal, J., Horne, D. A., Awasthi, S., & Singhal, S. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.002 · Cited by 576
The role of STAT3 in autophagy
You, L., Wang, Z., Li, H., Shou, J., Jing, Z., Xie, J., Sui, X., Pan, H., & Han, W. (2015) · Autophagy · doi:10.1080/15548627.2015.1017192 · Cited by 515
Self-citationMicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Zhang, L., Liao, Y., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1059-5 · Cited by 514
Mir-34: A New Weapon Against Cancer?
Misso, G., Martino, M. T. D., Rosa, G. D., Farooqı, A. A., Lombardi, A., Campani, V., Zarone, M. R., Gullà, A., Tagliaferri, P., Tassone, P., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.47 · Cited by 497
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Vu, T., & Datta, P. K. (2017) · Cancers · doi:10.3390/cancers9120171 · Cited by 510
Inflammatory networks underlying colorectal cancer
Lasry, A., Zinger, A., & Ben‐Neriah, Y. (2016) · Nature Immunology · doi:10.1038/ni.3384 · Cited by 497
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Huang, B., Lang, X., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023177 · Cited by 538
Weng, Y., Tseng, H., Chen, Y., Shen, P.-C., Haq, A. T. A., Chen, L., Tung, Y., & Hsu, H.-L. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0988-0 · Cited by 454
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. M. (2015) · Nature reviews. Immunology · doi:10.1038/nri3896 · Cited by 410
Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review
Cao, H., Xu, E., Liu, H., Wan, L., & Lai, M. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.05.010 · Cited by 367
The p53/miR-34 axis in development and disease
Rokavec, M., Li, H., Jiang, L., & Hermeking, H. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju003 · Cited by 358
Self-citationWen, S., Hou, Y., Fu, L., Xi, L., Yang, D., Zhao, M., Qin, Y., Sun, K., Teng, Y., & Liu, M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.015 · Cited by 351
Nucleic acid delivery for therapeutic applications
Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 351
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
Bocci, F., Gearhart-Serna, L., Boareto, M., Ribeiro, M. P. C., Ben‐Jacob, E., Devi, G. R., Levine, H., Onuchic, J. N., & Jolly, M. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815345116 · Cited by 300
Colorectal liver metastasis: molecular mechanism and interventional therapy
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00922-2 · Cited by 298
Pretzsch, E., Bösch, F., Neumann, J. H. L., Ganschow, P., Bazhin, A. V., Guba, M. O., Werner, J., & Angele, M. K. (2019) · Journal of Oncology · doi:10.1155/2019/7407190 · Cited by 308
De Marco, S., Sichetti, M., Muradyan, D., Piccioni, M., Traina, G., Pagiotti, R., & Pietrella, D. (2018) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2018/1756308 · Cited by 297
“PGE-2 is one of the major mediators of inflammation in colorectal cancer (CRC) development and progress [34], same as IL-6, which has been considered as a key regulator of CRCdevelopment [35] and increased quantities of plasma IL6were correlatedwith a poor prognosis in a variety of cancers, including colon cancer [36].”
BackgroundYin, Y., Yao, S., Hu, Y., Feng, Y., Li, M., Bian, Z., Zhang, J., Qin, Y., Qi, X., Zhou, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1283 · Cited by 296
An aberrant STAT pathway is central to COVID-19
Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K., & Mak, T. W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00633-7 · Cited by 295
Otmani, K., & Lewalle, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.708765 · Cited by 297
Alternative mechanisms of miR-34a regulation in cancer
Slabáková, E., Čulig, Z., Remšík, J., & Souček, K. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.495 · Cited by 275
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 266
Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis
Matsuyama, H., & Suzuki, H. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010132 · Cited by 258
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
Schulz‐Heddergott, R., Stark, N., Edmunds, S. J., Li, J., Conradi, L., Bohnenberger, H., Ceteci, F., Greten, F. R., Dobbelstein, M., & Moll, U. M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.004 · Cited by 243
Self-citationFeedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Zhao, C., Li, H., Lin, H.-J. L., Yang, S., Lin, J., & Liang, G. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.10.001 · Cited by 237
Self-citationBharti, R., Dey, G., & Mandal, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.048 · Cited by 230
A non-proliferative role of pyrimidine metabolism in cancer
Siddiqui, A., & Ceppi, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.005 · Cited by 223
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 223
Zhao, S., Mi, Y., Zheng, B., Wei, P., Gu, Y., Zhang, Z., Xu, Y., Cai, S., Li, X., & Li, D. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12186 · Cited by 211
Liu, Y., Sun, M., Xia, R., Zhang, E.-B., Liu, X.-H., Zhang, Z.-H., Xu, T.-P., De, W., Liu, B.-R., & Wang, Z.-X. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.150 · Cited by 207
Non-coding RNAs regulation of macrophage polarization in cancer
Mohapatra, S., Pioppini, C., Özpolat, B., & Călin, G. A. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01313-x · Cited by 209
Cell plasticity in epithelial homeostasis and tumorigenesis
Varga, J., & Greten, F. R. (2017) · Nature Cell Biology · doi:10.1038/ncb3611 · Cited by 209
Self-citationThe Two-Faced Cytokine IL-6 in Host Defense and Diseases
Narazaki, M., & Kishimoto, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113528 · Cited by 211
Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis
Liu, C., Rokavec, M., Huang, Z., & Hermeking, H. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01178-1 · Cited by 215
Self-citationMicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
To, K. K. W., Tong, C. W. S., Wu, M., & Cho, W. C. S. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i27.2949 · Cited by 197
He, Z., Wang, J., Zhu, C., Xu, J., Chen, P., Jiang, X., Chen, Y., Jiang, J., & Sun, C.-Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215751 · Cited by 203
Han, Y., Guo, W., Ren, T., Huang, Y., Wang, S., Liu, K., Zheng, B., Kang, Y., Zhang, H., & Liang, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.011 · Cited by 190
Maharati, A., & Moghbeli, M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01225-x · Cited by 191
Regulation of cancer metastasis by microRNAs
Chan, S., & Wang, L. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0113-7 · Cited by 179
Yue, B., Liu, C., Sun, H., Liu, M., Song, C., Cui, R., Qiu, S., & Zhong, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.024 · Cited by 175
The Developing Story of Predictive Biomarkers in Colorectal Cancer
Boussios, S., Öztürk, M. A., Moschetta, M., Karathanasi, A., Zakynthinakis-Kyriakou, N., Katsanos, K. H., Christodoulou, D. K., & Pavlidis, N. A. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010012 · Cited by 172
Tan, J., Qiu, K., Li, M., & Liang, Y. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.020 · Cited by 168
Targeting cancer‐related inflammation in the era of immunotherapy
Nakamura, K., & Smyth, M. J. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.126 · Cited by 164
A step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 163
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1
Liu, T., Yu, J., Deng, M., Yin, Y., Zhang, H., Luo, K., Qin, B., Li, Y., Wu, C., Ren, T., et al. (2017) · Nature Communications · doi:10.1038/ncomms13923 · Cited by 164
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1
Wang, Y., Lieberman, R., Pan, J., Zhang, Q., Du, M., Zhang, P., Nevalainen, M. T., Kohli, M., Shenoy, N. K., Meng, H., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0556-9 · Cited by 160
Xu, K., Zhan, Y., Yuan, Z., Qiu, Y., Wang, H., Fan, G., Wang, J., Li, W., Cao, Y., Shen, X., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.017 · Cited by 160
Li, H., Rokavec, M., Jiang, L., Horst, D. A., & Hermeking, H. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.017 · Cited by 160
Self-citationLiu, H., Ren, G., Wang, T., Chen, Y., Gong, C., Bai, Y., Wang, B., Qi, H., Shen, J., Zhu, L., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv017 · Cited by 150
Winck, F. V., Ribeiro, A. C. P., Domingues, R. R., Ling, L. Y., Riaño‐Pachón, D. M., Rivera, C., Brandão, T. B., Gouvêa, A. F., Santos‐Silva, A. R., Coletta, R. D., et al. (2015) · Scientific Reports · doi:10.1038/srep16305 · Cited by 154
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 149
MicroRNAs in the etiology of colorectal cancer: Pathways and clinical implications
Strubberg, A. M., & Madison, B. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027441 · Cited by 147
The Role of Interleukins in Colorectal Cancer
Li, J., Huang, L., Zhao, H., Yan, Y., & Lü, J. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.46651 · Cited by 155
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Raggi, C., Mousa, H. S., Correnti, M., Sica, A., & Invernizzi, P. (2015) · Oncogene · doi:10.1038/onc.2015.132 · Cited by 148
He, C., Yu, T., Shi, Y., Ma, C., Yang, W., Fang, L., Sun, M., Wu, W. H., Xiao, F., Guo, F., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.049 · Cited by 140
Zhu, X., Liang, R., Lan, T., Ding, D., Huang, S., Shao, J., Zheng, Z., Chen, T., Huang, Y., Liu, J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004219 · Cited by 143
Inflammation and cancer: tissue regeneration gone awry
Pesic, M. H., & Greten, F. R. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.07.010 · Cited by 137
Self-citationYou, Y., Tian, Z., Du, Z., Wu, K., Xu, G., Dai, M., Wang, Y., & Xiao, M. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02222-z · Cited by 134
Liu, Y., Luo, F., Xu, Y., Wang, B., Zhao, Y., Xu, W., Shi, L., Lü, X., & Liu, Q. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.10.022 · Cited by 125
Dou, R., Liu, K., Yang, C., Zheng, J., Shi, D., Lin, X., Chen, W., Zhang, C., Fang, Y., Huang, S., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.595 · Cited by 122
Du, Y., Long, Q., Zhang, L., SHI, Y., LIU, X., Li, X., GUAN, B., TIAN, Y., Wang, X., Li, L., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3202 · Cited by 127
MicroRNAs in colorectal carcinoma - from pathogenesis to therapy
Chi, Y., & Zhou, D. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0320-4 · Cited by 126
Zhou, Z., Xia, G., Xiang, Z., Liu, M., Wei, Z., Yan, J., Chen, W., Zhu, J., Awasthi, N., Sun, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3567 · Cited by 125
Gao, C., Ganesh, B. P., Shi, Z., Shah, R. R., Fultz, R., Major, A., Venable, S., Lugo, M., Hoch, K., Chen, X., et al. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.06.011 · Cited by 122
Li, H., Lan, T., Liu, H., Liu, C., Dai, J., Xu, L., Cai, Y., Hou, G., Xie, K., Liao, M., et al. (2021) · Hepatology · doi:10.1002/hep.32232 · Cited by 124
Self-citationXin, Y., Li, K., Huang, M. L., Liang, C., Siemann, D. W., Wu, L., Tan, Y., & Tang, X. (2023) · Oncogene · doi:10.1038/s41388-023-02844-x · Cited by 134
Mechanisms of Immune Signaling in Colitis-Associated Cancer
Waldner, M. J., & Neurath, M. F. (2014) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 119
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Goh, J. N., Loo, S. Y., Datta, A., Siveen, K. S., Yap, W. N., Cai, W., Shin, E. M., Wang, C., Kim, J. E., Chan, M., et al. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12176 · Cited by 121
Ge, X., Liu, X., Lin, F., Li, P., Liu, K., Geng, R., Dai, C., Lin, Y., Tang, W., Wu, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8228 · Cited by 118
The Emerging Roles of Exosomes as EMT Regulators in Cancer
Kim, H., Lee, S., Shin, E., Seong, K. M., Jin, Y. W., Youn, H., & Youn, B. (2020) · Cells · doi:10.3390/cells9040861 · Cited by 124
Wu, J. T., Zhang, J., Shen, B., Yin, K., Xu, J., Gao, W., & Zhang, L. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0229-3 · Cited by 117
RetractedThe tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas
Adams, B. D., Parsons, C., & Slack, F. J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1114102 · Cited by 121
Emerging Concepts Linking Obesity with the Hallmarks of Cancer
Donohoe, C. L., Lysaght, J., O'Sullivan, J. N., & Reynolds, J. V. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.08.004 · Cited by 122
Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression
Rokavec, M., Kaller, M., Horst, D. A., & Hermeking, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-04234-2 · Cited by 115
Self-citationTargeting STAT3 Signaling Pathway in Colorectal Cancer
Gargalionis, A. N., Papavassiliou, K. A., & Papavassiliou, A. G. (2021) · Biomedicines · doi:10.3390/biomedicines9081016 · Cited by 115
IL-33/ST2 pathway contributes to metastasis of human colorectal cancer
Liu, X., Zhu, L., Lu, X., Bian, H.-R., Wu, X., Yang, W., & Qin, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.106 · Cited by 114
MicroRNAs as regulators and mediators of c-MYC function
Jackstadt, R., & Hermeking, H. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.003 · Cited by 117
Self-citationRokavec, M., Horst, D. A., & Hermeking, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3236 · Cited by 113
Self-citationQu, L., Wu, Z., Li, Y., Xu, Z., Liu, B., Liu, F., Bao, Y., Wu, D.-S., Liu, J., Wang, A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12692 · Cited by 112
Yu, D., Ye, T., Xiang, Y., Shi, Z., Zhang, J., Lou, B., Zhang, F., Chen, B., & Zhou, M. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s136840 · Cited by 112
Zhao, S., Li, T., Li, J., Lu, Q., Han, C., Wang, N., Qiu, Q., Cao, H., Xu, X., Chen, H., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3832-0 · Cited by 111
MicroRNA-34a: the bad guy in age-related vascular diseases
Raucci, A., Macrì, F., Castiglione, S., Badi, I., Vinci, M. C., & Zuccolo, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03979-4 · Cited by 118
JAK‐STAT core cancer pathway: An integrative cancer interactome analysis
Erdogan, F., Radu, T. B., Orlova, A., Qadree, A., de Araujo, E. D., Israelian, J., Valent, P., Mustjoki, S. M., Herling, M., Moriggl, R., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17228 · Cited by 111
Hu, H., Cheng, R., Wang, Y., Wang, X., Wu, J., Kong, Y., Zhan, S., Zhou, Z., Zhu, H., Yu, R., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153470 · Cited by 111
The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
Romeo, E. L., Caserta, C. A., Rumio, C., & Marcucci, F. (2019) · Cells · doi:10.3390/cells8050460 · Cited by 115
Wang, Y., Jing, Y., Ding, L., Zhang, X., Song, Y., Chen, S., Zhao, X., Huang, X., Pu, Y., Wang, Z., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1277-x · Cited by 109
STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
Saitoh, M., Endo, K., Furuya, S., Minami, M., Fukasawa, A., Imamura, T., & Miyazawa, K. (2015) · Oncogene · doi:10.1038/onc.2015.161 · Cited by 106
Metadata
- Authors
- Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., & Hermeking, H.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Universitätsmedizin Göttingen (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1853-1867
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3973098
- OpenAlex
- W2104268053
- Cited by
- 753
- References
- 66
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 60 · 2023: 66 · 2022: 90 · 2021: 69 · 2020: 66 · 2019: 76 · 2018: 59 · 2017: 69 · 2016: 65 · 2015: 66 · 2014: 20
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Johns Hopkins University (HCT116)
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Deutschen Konsortium für Translationale Krebsforschung
- FP7 Ideas: European Research Council (281967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- colorectal cancer, epithelial-mesenchymal transition, interleukin-6, IL-6 receptor, STAT3, miR-34a, feedback loops, tumor invasion, metastasis, p53, snails, microRNA regulation
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Female, Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Transcription Factors, Colorectal Neoplasms, Mice, Knockout, Receptors, Interleukin-6, Feedback, Physiological, MicroRNAs, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review